Biology • Year 12 • Module 8 • Lesson 1

Homeostasis — Stimulus-Response, Feedback Loops and the Internal Environment

Build HSC Band 5–6 extended-response technique on homeostasis, feedback mechanisms, and the clinical consequences of disrupted regulation.

Master · Extended Response

1. Data-driven extended response — ICU glucose management and homeostatic disruption (Band 5–6)

8 marks   Band 5–6

Stimulus. A 2009 study published in the New England Journal of Medicine (NICE-SUGAR trial, Finfer et al.) randomised 6104 critically ill patients in intensive care units across Australia and New Zealand. One group received intensive glucose control (target blood glucose 4.5–6.0 mmol/L, requiring continuous insulin infusion) and the other received conventional glucose control (target 10 mmol/L or below). The primary outcome (90-day mortality) was higher in the intensive-control group (27.5%) than the conventional group (24.9%). The main cause of death difference was cardiovascular. A major adverse event in the intensive-control group was severe hypoglycaemia (blood glucose <2.2 mmol/L), which occurred in 6.8% of intensive-control patients versus 0.5% of conventional patients.

0% 10% 20% 30% Outcome rate (%) 27.5% 24.9% 90-day mortality 6.8% 0.5% Severe hypoglycaemia Intensive control (4.5–6.0 mmol/L) Conventional control (≤10 mmol/L)
Figure 1.1 — Selected outcomes from the NICE-SUGAR trial (Finfer et al., 2009, NEJM 360:1283–1297). 6104 ICU patients across Australia and New Zealand.

Q1. Analyse and evaluate, using the lesson’s framework of homeostasis and feedback loops, the paradox revealed by the NICE-SUGAR trial: why did keeping blood glucose closer to the normal homeostatic tolerance range (intensive control) lead to worse patient outcomes than conventional control?

In your response you must:

  • Define homeostasis and state the normal blood glucose tolerance range and its importance for cellular function.
  • Explain, using the stimulus-response model, what happens when blood glucose falls below the lower tolerance limit (severe hypoglycaemia) — name all five components.
  • Compare the homeostatic consequences of blood glucose at 2.2 mmol/L versus at 10 mmol/L, referring to enzyme function, cellular respiration, and organ damage.
  • Evaluate which disruption (hypoglycaemia vs moderate hyperglycaemia) poses the more immediate risk to the ICU patient, using evidence from the figure.
  • Reach a justified conclusion that frames the trial result in terms of the body’s homeostatic tolerance range rather than simply “tight control is bad”.
Stuck? Plan: definition (homeostasis, tolerance range) → pathway for hypoglycaemia → compare 2.2 vs 10 mmol/L against enzymatic optimum → use figure data → conclude. The lesson’s ICU anchor callout is directly relevant here.

2. Evaluate a claim — “positive feedback is always pathological” (Band 5–6)

7 marks   Band 5–6

“Positive feedback always represents a failure of homeostasis. Any time a biological system uses positive feedback, the result is pathological — the variable is driven away from the set point without any corrective mechanism to bring it back. True homeostasis only ever uses negative feedback. Positive feedback should be thought of as what happens when homeostasis breaks down.”

Q2. Evaluate this claim. Identify which parts are scientifically defensible and which are incorrect or overstated. Reformulate the claim into a biologically accurate statement that correctly captures the roles of both feedback types in human physiology.

Your response must:

Stuck? Revisit lesson § Card 3 and the Misconceptions box. Also: blood clotting (wound sealing), action potential firing, and fever escalation are all useful examples.
Answers — Do not peek before attempting

Q1 — Sample Band 6 response (8 marks), annotated

Homeostasis is the maintenance of a relatively stable internal environment, kept within a tolerance range despite changes in the external or internal environment. For blood glucose, the normal tolerance range is approximately 4.0–6.0 mmol/L. This narrow range is critical because the enzymes driving cellular respiration — including those in the glycolytic pathway and the tricarboxylic acid cycle — have optimal substrate concentrations and are impaired at both extremes. Neurons are particularly vulnerable because the brain relies almost exclusively on glucose for ATP production and has minimal glycogen stores. [1 — definition + tolerance range + cellular rationale]

When blood glucose falls below the lower tolerance limit (<4.0 mmol/L) — and catastrophically below 2.2 mmol/L as occurred in 6.8% of intensive-control patients — the stimulus-response model operates: Stimulus = blood glucose below tolerance range; Receptor = alpha cells in the islets of Langerhans (also glucoreceptors in the hypothalamus) detect the hypoglycaemia; Control centre = hypothalamus processes the signal and the adrenal medulla is activated; Effector = alpha cells release glucagon; adrenal medulla releases adrenaline; Response = liver converts glycogen to glucose (glycogenolysis), gluconeogenesis is stimulated, and adrenaline increases heart rate and diverts blood to vital organs. This is negative feedback — the response opposes the fall in blood glucose. [1 — all five components named correctly for hypoglycaemia]

A blood glucose of 2.2 mmol/L (as in severe hypoglycaemia) deprives neurons and cardiac cells of glucose below the threshold for adequate ATP production. Without ATP, Na/K pumps fail, action potentials cannot be repolarised, and the brain enters an energy crisis — manifesting as confusion, seizures, unconsciousness, and if uncorrected, death. Cardiac arrhythmias due to electrolyte disturbance in hypoglycaemia explain why cardiovascular causes of death were elevated in the intensive-control group. By contrast, blood glucose at 10 mmol/L (the conventional group target) is above the normal upper tolerance range but not an acute metabolic emergency. At 10 mmol/L, cellular respiration proceeds, neurons function, and the acute risk of organ failure is far lower. The damage from moderate chronic hyperglycaemia (osmotic damage to blood vessel walls, glycation of proteins) occurs over weeks to months — not within the hours of an ICU admission. [1 — comparison of 2.2 vs 10 mmol/L against enzyme/cellular function; 1 — identifies immediate vs long-term timescales of damage]

The figure shows that severe hypoglycaemia occurred in 6.8% of intensive-control patients versus 0.5% in the conventional group — a 13-fold difference. The 2.6 percentage-point difference in 90-day mortality (27.5% vs 24.9%) is consistent with hypoglycaemia-induced cardiovascular events being the proximate cause of the excess deaths. [1 — data from figure used to support argument]

The paradox is therefore resolved by the concept of the tolerance range: the intensive-control protocol was designed to restore homeostasis by bringing glucose to within the normal range, but in a critically ill patient whose own negative feedback mechanisms (glucagon, adrenaline) are impaired by illness, sedation, or organ failure, the insulin infusion could not be finely titrated — resulting in glucose falling below the tolerance range. A homeostatic system maintained artificially must respect both limits of the tolerance range, not only the upper one. The trial conclusion is not “tight control is bad” but rather: “in ICU patients unable to mount a full endogenous counter-regulatory response, the risk of artificially induced hypoglycaemia (breaching the lower limit) outweighs the benefit of avoiding moderate hyperglycaemia (breaching the upper limit).” [1 — resolves paradox with tolerance range framework; 1 — justified, nuanced conclusion; 1 — acknowledges impaired endogenous counter-regulation]

Marking criteria (8 marks):

  • 1 mark — Defines homeostasis correctly; states blood glucose tolerance range (4.0–6.0 mmol/L) and links to cellular/enzyme function.
  • 1 mark — Names all five components of the stimulus-response pathway correctly for hypoglycaemia correction.
  • 1 mark — Compares 2.2 mmol/L vs 10 mmol/L against cellular function (neurons, cardiac muscle, ATP production).
  • 1 mark — Identifies that hypoglycaemia poses an immediate metabolic risk (minutes to hours) whereas moderate hyperglycaemia is a long-term risk (weeks–months).
  • 1 mark — Uses specific data from Figure 1.1 (rates of hypoglycaemia and/or mortality) to support the argument.
  • 1 mark — Identifies the mechanism by which the lower tolerance limit was breached: exogenous insulin without adequate endogenous counter-regulation in a critically ill patient.
  • 1 mark — Frames the paradox using the concept of the bilateral tolerance range (both upper and lower limits matter).
  • 1 mark — Reaches a justified, nuanced conclusion in homeostatic terms (not simply “tight control is bad”).

Q2 — Sample Band 6 response (7 marks), annotated

The claim is substantially flawed, though it contains one defensible element. [1 — evaluative judgement stated]

What is defensible: Positive feedback does move the variable further from the set point, and negative feedback is the primary mechanism of homeostasis (it produces a response that opposes the original stimulus, returning the variable toward the set point). [1 — correct distinction between feedback types, direction stated]

What is wrong: The claim that positive feedback is always pathological is false. There are multiple examples of normal, healthy positive feedback loops that are essential for survival:

  • Childbirth (oxytocin loop): Uterine contractions stretch the cervix → oxytocin is released from the posterior pituitary → contractions intensify → more cervical stretch → more oxytocin. This amplifying loop drives labour to completion (the external endpoint: delivery of the baby removes the stimulus of cervical stretch). This is not pathological — it is a coordinated physiological process that enables reproduction. [1 — childbirth example with mechanism and external endpoint]
  • Blood clotting cascade: Platelet adhesion to damaged vessel walls → clotting factors released → more platelets recruited → more clotting factors → rapid clot formation. The external endpoint is wound sealing — once the endothelial surface is covered, the stimulus (exposed collagen) is removed and the loop stops. Without this positive feedback, minor cuts would bleed indefinitely. [1 — second healthy positive feedback example with external endpoint]

When positive feedback IS pathological: Fever escalation provides the key counterexample within a homeostatic system. In severe infection, rising body temperature can trigger increased metabolic rate → more heat generation → further temperature increase → more metabolic activity. If this loop is not interrupted by medical intervention (antipyretics, cooling) or the immune system resolving the infection, it can drive body temperature beyond 40°C, causing protein denaturation, seizures, and multi-organ failure. Here, positive feedback is operating within a system meant to maintain homeostasis, and there is no natural external endpoint — which is what makes it genuinely pathological. [1 — pathological example (fever escalation) with explanation of why — no natural external endpoint within the homeostatic system]

The key distinction is this: healthy positive feedback operates in systems specifically designed to drive a process to a definite external completion event (birth, wound closure, action potential firing). In these systems, the amplifying loop is not a failure of homeostasis — it is a different biological function (rapid completion) that operates alongside homeostatic systems. Positive feedback becomes pathological when it operates within a homeostatic variable (e.g. body temperature) without a natural external endpoint, because the variable then has no mechanism to return to the set point on its own. [1 — explains what stops healthy positive feedback vs why pathological loops are dangerous]

Defensible reformulation: “Negative feedback is the primary mechanism of homeostasis, producing responses that oppose deviations and return variables to their set point. Positive feedback amplifies deviations and is not a homeostatic mechanism. However, positive feedback is a normal and essential physiological mechanism in certain contexts — including childbirth and blood clotting — where it drives a process rapidly to a natural completion endpoint. Positive feedback is pathological only when it operates within a homeostatic variable without a natural external endpoint to stop it, as in fever escalation.” [1 — defensible reformulation incorporating both feedback types correctly]

Marking criteria (7 marks):

  • 1 mark — States an overall evaluative judgement on the claim (e.g. “substantially flawed”).
  • 1 mark — Correctly distinguishes negative from positive feedback using the direction of the response relative to the stimulus.
  • 1 mark — Provides the childbirth/oxytocin example of healthy positive feedback, with mechanism and external endpoint.
  • 1 mark — Provides a second healthy positive feedback example (blood clotting / action potential firing) with mechanism and external endpoint.
  • 1 mark — Provides fever escalation (or equivalent) as an example of pathological positive feedback and explains why it is pathological (no natural external endpoint within the homeostatic system).
  • 1 mark — Explains the key distinction: healthy positive feedback has a definite external completion event; pathological positive feedback lacks this in a homeostatic context.
  • 1 mark — Reformulates the claim into a biologically defensible statement that correctly frames both feedback types.